Shervanthi Homer-Vanniasinkam
Director/Board Member chez TISSUE REGENIX GROUP PLC
Fortune : 12 855 $ au 31/03/2024
Profil
Shervanthi Homer-Vanniasinkam is an Independent Non-Executive Director at Tissue Regenix Group Plc since 2016.
She is also a Professor at the University of Warwick, University College London, and University Hospitals Coventry & Warwickshire NHS Trust.
She completed her undergraduate degree from the University of Mysore in 1981.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
TISSUE REGENIX GROUP PLC
0,02% | 31/12/2023 | 16 282 ( 0,02% ) | 12 855 $ | 31/03/2024 |
Postes actifs de Shervanthi Homer-Vanniasinkam
Sociétés | Poste | Début |
---|---|---|
TISSUE REGENIX GROUP PLC | Director/Board Member | 01/06/2016 |
University College London | Corporate Officer/Principal | - |
University of Warwick | Corporate Officer/Principal | - |
University Hospitals Coventry & Warwickshire NHS Trust
University Hospitals Coventry & Warwickshire NHS Trust Hospital/Nursing ManagementHealth Services University Hospitals Coventry & Warwickshire NHS Trust provides healthcare services. The non-profit company is based in Coventry, UK and has subsidiaries in the United Kingdom. The British company was founded in 1992. The CEO is Andrew Hardy. | Corporate Officer/Principal | - |
Formation de Shervanthi Homer-Vanniasinkam
University of Mysore | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
TISSUE REGENIX GROUP PLC | Health Technology |
Entreprise privées | 1 |
---|---|
University Hospitals Coventry & Warwickshire NHS Trust
University Hospitals Coventry & Warwickshire NHS Trust Hospital/Nursing ManagementHealth Services University Hospitals Coventry & Warwickshire NHS Trust provides healthcare services. The non-profit company is based in Coventry, UK and has subsidiaries in the United Kingdom. The British company was founded in 1992. The CEO is Andrew Hardy. | Health Services |